641 |
Fonction et dysfonction des systèmes d'efflux actif chez les souches cliniques de pseudomonas aeruginosa / Function and dysfunction of active efflux systems in clinical strains of pseudomonas aeruginosaGuénard, Sophie 08 October 2013 (has links)
Chez P. aeruginosa, la surproduction constitutive du système MexXY/OprM s'accompagne d'une augmentation de larésistance aux aminosides, fluoroquinolones et à certaines (3-lactamines. La caractérisation des mécanismes génétiquesconduisant à la surproduction de cette pompe parmi une collection de 57 isolats cliniques non redondants a permisd'identifier 3 types de mutations affectant, soit le gène mexZ dont le produit réprime l'opéron mexXY (mutants agrZ,77,2%), soit les gènes parRS codant pour un système à deux composants (mutants agrWl, 8,8%) ou d'autres cibles dontl'inactivation perturbe la synthèse protéique et entraîne la surexpression du gène PA5471 dont le produit, ArmZ, est unanti-répresseur de MexZ (mutants agrWl,\4%). Si certaines populations de P. aeruginosa tendent à devenir plusrésistantes aux aminosides en surproduisant le système MexXY/OprM, d'autres évoluent paradoxalement vers unehypersensibilité aux p-lactamines sous l'effet de mutations inactivant MexAB-OprM (MexAB-). L'analyse d'unecollection de 275 souches isolées de 36 patients CF nous a permis d'identifier des souches MexAB- hypersensibles à laticarcilline (37%) et des souches MexAB- non hypersensibles en raison d'une surproduction de la B-lactamase AmpC(16%). Au total, 53% des isolats sont apparus déficients dans le système MexAB-OprM. L'étude de l'activité ou de laproduction de divers facteurs de virulence a indiqué que la perte de fonction de MexAB-OprM n'était pas associée àcelle de caractères de virulence. Au final, notre travail apporte un éclairage nouveau sur la capacité de P. aeruginosa àmoduler l'activité de ses pompes d'efflux pour s'adapter à diverses situations cliniques. / Pseudomonas aeruginosa is a nosocomial pathogen naturally resistant to many antibiotics thanks to numerous resistantmechanisms. Among them, overproduction of the MexXY/OprM efflux System leads to decrease significantly thesusceptibility of P. aeruginosa to aminoglycosides, fluoroquinolones and some p-lactams. Characterization of geneticmechanisms leading to overproduction of this pump from a collection of 57 non-redundant clinical isolates enable toidentified three types of mutations affecting either the gene mexZ whose product represses mexXY operon (agrZmutants, «=77. 2%), or genes parRS encoding a two component System (agrW2 mutants, w=8.8%) or other targetswhose inactivation disturbs protein synthesis and results in overexpression of the gene PA547I, whose product ArmZ isan anti-repressor of MexZ protein (agrWl mutants, n= 14%). If some populations of A aeruginosa are becoming moreresistant to aminoglycosides by overproducing MexXY/OprM system, others develop an hypersensitivity to P-lactamsas a resuit of mutations inactivating MexAB-OprM efflux system (MexAB-). The analysis of 275 strains isolated from36 CF patients allowed us to identify MexAB- strains hypersensitive to ticarcillin (37%) and non-MexABhypersensitive strains due to an overproduction of the p-lactamase AmpC (16%). In fine, 53% of the isolates appeareddeficient in MexAB-OprM. The study of various virulence factors indicated that the loss of function of MexAB-OprMin P. aeruginosa was not associated with virulence of the strains. To conclude, our work highlight on the ability ofP. aeruginosa to modulate the activity of its efflux pumps in order to adapt to various clinical environments
|
642 |
Pseudomonas aeruginosa en réanimation : épidémiologie et facteurs de risque d’acquisition / Pseudomonas aeruginosa in intensive care unit : epidemiology and risk factors for acquisitionVenier, Anne-Gaëlle 08 December 2011 (has links)
Malgré les avancées en matière de prévention, Pseudomonas aeruginosa reste un pathogène fréquent et délétère en réanimation. Des facteurs de risque d’acquisition de ce micro-organisme ont déjà pu être identifiés, mais jamais dans un contexte multicentrique et rarement en ajustant sur des caractéristiques du service. Si l’analyse de la littérature était jusqu’alors en faveur d’une forte origine individuelle, la part du contexte d’hospitalisation et des caractéristiques de la réanimation paraît de moins en moins négligeable. Notre travail a permis non seulement de faire un état des lieux concernant les connaissances actuelles sur Pseudomonas aeruginosa en réanimation mais également d’identifier des profils type de patients et services de réanimation plus à risque vis à vis de ce micro-organisme. L’intérêt majeur est non seulement de pouvoir ainsi orienter les cliniciens face à une conjonction d’éléments mais surtout, là où les facteurs patients restent souvent peu modifiables, d’identifier des éléments contextuels d’acquisition sur lesquels il serait possible d’agir afin de réduire le risque infectieux. / Despite major advance in techniques and reinforcement of infection control measures, Pseudomonas aeruginosa remains frequent in intensive care unit (ICU) and is responsible for severe hospital-acquired infections. Several patient and pathogen-specific risk factors have been associated with acquisition of P. aeruginosa in ICUs Nevertheless those risk factors were identified in monocentric studies which rarely took in account the context of cares. If individual risk factors for P. aeruginosa acquisition have appeared to be predominant since then, the role of contextual variables seems to have been underestimated. This thesis provides insight into the epidemiology of P. aeruginosa in ICU, identifies individual and contextual risk factors for P. aeruginosa infection and P. aeruginosa acquisition and emphasizes the interest of contextual variables which gives new perspectives to P. aeruginosa prevention.
|
643 |
Pyrimidine Enzyme Specific Activity at Four Different Phases of Growth in Minimal and Rich Media, and Concomitant Virulence Factors Evaluation in Pseudomonas aeruginosaAzad, Kamran Nikkhah 12 1900 (has links)
Pseudomonas aeruginosa is a Gram-negative rod, aerobic, non-fermenting, oxidase positive, pigment producing, and nutritionally versatile bacterium. Infections by P. aeruginosa are the most important cause of morbidity and mortality in immunocompromised patients, given virulence factor production that suppresses antibiotic therapy and promotes persistent infection. This research is the first comprehensive report of the pyrimidine biosynthetic pathway for all phases of growth in minimal and rich media coupled with the evaluation of virulence factor production of P. aeruginosa in comparison to four other bacterial species (Pseudomonas putida, Pseudomonas fluorescens, Burkholderia cepacia, and Escherichia coli wild-type strains). Cellular growth and passing genetic information to the next generation depend on the synthesis of purines and pyrimidines, the precursors of DNA and RNA. The pyrimidine biosynthetic pathway is essential and found in most organisms, with the exception of a few parasites that depend upon the pyrimidine salvage pathway for growth. Both the pyrimidine biosynthetic and salvage enzymes are targets for chemotherapeutic agents. In our laboratory, research on pyrimidine auxotrophic mutants showed the role of the pyrimidine biosynthetic pathway and its intermediates on P. aeruginosa metabolism and impaired virulence factors production. The present research shows that pyrimidine enzymes are active in all phases of growth, including the production of two forms of ATCase in the late log phase in P. aeruginosa. This finding may be explained by the displacement of the inactive PyrC' by the active PyrC or PyrC2 to form a new and larger pyrBC encoded ATCase. Pseudomonas aeruginosa wild-type appears to produce by far the most virulence factors, haemolysin, iron chelation, rhamnolipid, adherence, and three types of motility (swimming, swarming, and twitching) investigated in this study, when compared to the other four wild-type strains. Growth analysis was carried out as typically done in minimal medium but also in rich medium to simulate conditions in the blood and lung tissues of humans as P. aeruginosa infections develop.
|
644 |
Rôle de la porine OprD et du système d'efflux MexEF-OprN dans la résistance des souches cliniques de Pseudomonasb aeruginosa aux antibiotiques / Role of porin OprD and MexEF-OprN efflux system in antibiotic resistance of Pseudomonas aeruginosa clinical isolateRichardot, Charlotte 03 December 2015 (has links)
Pseudomonas aeruginosa est un pathogène opportuniste majeur des patients atteints de mucoviscidose. Les infections à P. aeruginosa sont souvent difficiles à traiter, notamment en raison de sa capacité à développer des résistances à plusieurs familles d'antibiotiques. Dans les années 1980, les carbapénèmes font leur apparition dans l'arsenal anti-pyocyanique. Toutefois, les premiers cas de résistance apparaissent rapidement en raison de la« perte» de la porine OprD, voie d'entrée spécifique de ces antibiotiques dans la bactérie. L'étude de 173 souches cliniques de P. aeruginosa, a permis de caractériser les mécanismes à l'origine de cette résistance. La perte de la porine résulte de mutations inactivant le gène oprD ou se traduisant par des substitutions d'acides aminés responsables d'altérations structurales de la porine. Le gène oprD peut également être réprimé par certains régulateurs de pompes d'efflux telles que MexEF-OprN. La surproduction de ce système suite à l'inactivation d'une oxydoréductase, MexS, chez les mutants nfxC in vitro, confère une résistance conjointe à plusieurs familles d'antibiotiques ainsi que la perte de la production de nombreux facteurs de virulence. Toutefois, les altérations retrouvées dans la protéine MexS de 22 mutants nfYC cliniques sont majoritairement des substitutions d'acides aminés qui compromettent peu la virulence. L'origine de la surproduction de la pompe MexEF-OprN et de la multi-résistance qui lui est associée chez les souches cliniques s'est révélée indépendante de mutations dans le gène mexS chez près de la moitié des isolats, indiquant indirectement la participation d'autres gènes dans la régulation de ce système d' efflux. / Pseudomonas aeruginosa is an opportunistic pathogen which contributes to the decline of respiratory function in cystic fibrosis patients. Shortly after infection, the bacterium is able to develop various strategies to resist antibiotics of different classes. ln 1980's, new antibiotics, called carbapenems, are developed for anti-pyocyanic treatments. However, isolation of carbapenem resistant clinical strains of P. aeruginosa increases. Resistance to carbapenem mainly results from loss of porin OprD, the major route of entry of these molecules in the bacteria. Aim of this study is to characterize the mechanisms of this resistance through 173 clinical isolates of P. aeruginosa. Loss of porin OprD is mostly due to mutations inactivating oprD gene or generating deleterious amino-acid substitutions in the porin structure. Gene oprD can also be down-regulated by efflux system regulators such as Mexî, the transcriptional activator of MexEF-OprN efflux pump. Overexpression of mexEF-oprN in laboratory-selected nfxC mutants is caused by inactivation of an oxydoreductase, MexS, leading to resistance to fluoroquinolones, chloramphenicol and carbapenem and loss of production of several virulence factors. Analysis of 22 non-redundant clinical nfxC mutants showed that (i) in contrast to in vitro selected counterparts only 3 of them harbored a disrupted gene mexS, (ii) 9 contained amino-acid substitutions in MexS associated with moderate effects on resistance an virulence factors production and (iii) 1 O did not display mutations in any of the regulators known to control mexEF-oprN expression, indicating that other loci are responsible for the pump upregulation.
|
645 |
Rôles du facteur sigma à fonction extracytoplasmique SigX dans l'adaptation, la formation de biofilm et la réponse à des stress de l'enveloppe chez Pseudomonas aeruginosa. / Role of the Extracytoplasmic function sigma factor SigX in biofilm formation and response to antimicrobials in Pseudomonas aeruginosaDuchesne, Rachel 06 January 2017 (has links)
Pseudomonas aeruginosa est un pathogène opportuniste de l’Homme responsable de nombreuses infections des voies pulmonaires et urinaires chez des patients immunodéprimés. Largement étudié pour son implication dans la sévérité des symptômes liés à la mucoviscidose, le« bacille pyocyanique » constitue un enjeu majeur en termes de sécurité sanitaire puisqu’il représente après Escherichia coli et Staphylococcus aureus la 3ème cause d’infections nosocomiales en France (INVS, Enquête nationale de prévalence des infections nosocomiales en France, 2012). La persistance de P. aeruginosa notamment dans le cadre médical, est largement due à sa grande capacité à s’adapter et à se développer en communauté organisée au sein de biofilm. Le génome de P. aeruginosa contient de nombreux gènes codant des systèmes de régulation dont la majorité est impliquée dans des mécanismes de perception-transduction de signaux, conférant à la bactérie son fort pouvoir d’adaptation. Parmi ces systèmes, les facteurs sigma à fonction extracytoplasmique (ECF), des sous-unités transitoires de l’ARN polymérase, jouent un rôle fondamental dans la résistance et l’adaptation aux stress. SigX est un facteur sigma ECF, impliqué dans la virulence et la formation de biofilms, ainsi que dans la production des acides gras à courte chaine. Au cours de cette étude, les fonctions cellulaires de SigX ont été précisées, Nous avons montré que SigX joue un rôle important dans la composition, la fluidité et la perméabilité membranaires, et par conséquent dans le métabolisme de la cellule. L’activation de SigX en réponse à des conditions entrainant un stress de l’enveloppe, telles que la perte de la porine majoritaire OprF, la présence d’une concentration de sucrose dans le milieu de culture ou d’une concentration sub-inhibitrice de tobramycine, suggère que cet ECF, comme AlgU, pourrait appartenir à la classe des ECF de type RpoE.De manière remarquable, certaines altérations de l’enveloppe pourraient induire la formation de biofilm, un phénotype impliquant au moins partiellement SigX. Il conviendra à présent de caractériser les mécanismes moléculaires conduisant à l’activation de SigX et de préciser le rôle de ce facteur sigma dans la formation de biofilm. / Pseudomonas aeruginosa is a major opportunistic pathogen causing many infectious diseases in immunocompromised patients. Widely studied because of its involvement in lung infections of cysticfibrosis suffering patients, this bacterium is a major public health challenge. P. aeruginosa persistence is largely due to its ability to adopt a multicellular lifestyle called biofilm. P. aeruginosa genome encodes numerous genes predicted to be involved in signal transduction allowing this bacterium to adapt to many environments. Among these systems, the extracytoplasmic function sigma factors, which are transitory subunits of the RNA polymerase, are of major importance for stress resistance and adaptation. SigX is an ECF sigma factor that has been involved in virulence, biofilm formation and in short chain fatty acidsbiosynthesis. This work led to precise the cellular functions of SigX. We have shown that SigX is of major importance for membrane homeostasis, including composition, fluidity and permeability. As a consequence, SigX was shown to be involved in P. aeruginosa metabolism. SigX activity is enhanced in conditions leading to a cell wall stress, as the lack of the major outer membrane porin OprF, high concentrations of sucrose or sublethal concentration of tobramycin, suggesting that this ECF, as AlgU,is a new cell wall stress responsive sigma factor. Remarkably, some alterations could induce biofilm formation, a phenotype involving at least partially SigX. The molecular mechanisms leading to SigX activity should now be deciphered and the role of this ECF in biofilm formation should be precised.
|
646 |
Estudo da função do gene kerV de Pseudomonas aeruginosa / Function of Pseudomonas aeruginosa kerV geneDiogo de Abreu Meireles 08 September 2011 (has links)
P. aeruginosa PA14 é uma linhagem isolada de queimadura que apresenta vários fatores de patogenicidade comuns no quadro de infecção de hospedeiros filogeneticamente distintos (plantas, mamíferos ou invertebrados). O gene kerV foi revelado numa busca por mutantes atenuados em virulência em uma biblioteca de mutantes por transposons da linhagem PA14 (Rahme et al., 1997). A caracterização da linhagem D12, mutante em kerV, confirmou sua virulência atenuada (Apidianakis et al., 2005 e An et al., 2009) e resultados do transcriptoma mostraram alteração na expressão de mais de 500 genes, sendo alguns relacionados com o sistema de \"quorum sensing\" (Rahme et al, dados não publicados). O gene kerV está próximo à montante ao gene gloB, envolvido em detoxificação de metilglioxal, e à jusante aos genes rnhA e dnaQ, que codificam proteínas envolvidas na replicação e reparo do DNA. Este trabalho teve como objetivo estudar a função molecular do produto de kerV e a expressão dos genes do lócus kerV-rnhA-dnaQ. Análises de bioinformática indicam que a proteína KerV é uma metiltransferase dependente de S-adenosil-metionina (SAM), apresentando um domínio conservado de ligação a SAM e uma arquitetura de domínio compatível com a organização em fitas-beta e hélices-alfa alternadas descritas para a família das metiltransferases dependentes de SAM. Ela não apresenta outros domínios conservados que indiquem seu substrato de metilação. A expressão heteróloga desta proteína em E. coli, mostrou que ela é expressa de maneira parcialmente solúvel quando co-expressa com as chaperoninas GroEL/GroES em baixas temperaturas ou quando fusionada a MBP ou GST. A purificação desta proteína mostra que ela é co-eluída com a chaperonina GroEL sugerindo que para atingir sua conformação nativa ela necessita dessas proteínas acessórias. MBP-KerV purificado foi usado para ensaios \"in vitro\" de atividade de metiltransferase e ligação a SAM, que não foram conclusivos, pois não há certeza do seu correto estado de enovelamento. Ensaios de duplo-híbrido mostraram que KerV não interage com os produtos de rnhA e dnaQ, sugerindo que KerV não está diretamente relacionado com suas funções. A freqüência de mutação na linhagem D12 está levemente aumentada (aproximadamente quatro vezes), o que sugere que KerV não está diretamente envolvida no reparo de DNA do tipo ´mismatch repair`. Os ensaios usados para detectar metilação do DNA, proteínas e rRNAs não revelaram que KerV estaria envolvido com a metilação destes substratos. Os inícios de transcrição dos genes kerV, rnhA e dnaQ foram determinados. A deleção de kerV causa um efeito polar na transcrição do gene rnhA, que não se reflete nos níveis da proteína. A deleção também afeta a expressão de dnaQ, sugerindo que KerV seja importante para sua regulação. Os ensaios de complementação da virulência em modelos invertebrados e de células epiteliais de pulmão mostram que apenas a presença dos três genes e seus produtos em níveis normais são capazes de reverter a maioria dos fenótipos atenuados. KerV se mostrou essencial para a inibição da translocação de NF-kB para o núcleo das células, comprovando que esta proteína é relevante para a virulência de PA14, contribuindo com o silenciamento da resposta imune do hospedeiro. O conjunto dos resultados indicam uma complexa inter-relação entre a expressão dos genes kerV, rnhA e dnaQ e seu papel na biologia de P. aeruginosa. / P. aeruginosa PA14 is a burn isolate multi-host pathogen strain. The screening for virulence attenuated mutants in a PA14 transposon mutant library revealed the kerV gene (Rahme et al., 1997). The characterization of D12 strain, a kerV mutant, confirmed the attenuated virulence phenotype (Apidianakis et al., 2005 and An et al., 2009) and transcriptome analysis showed the expression of more than 500 genes are affected in D12, some of these genes are related with quorum sensing (Rahme et al, unpublished data). kerV is upstream of the gloB gene, related with methylglioxal detoxification and downstream of the rnhA and dnaQ genes, both related with DNA replication and repair. The purpose of this work was to study the molecular function of KerV product and the expression of kerV-rnhA-dnaQ locus. Bioinformatics analysis indicated that KerV is a SAM dependent methyltransferase that have a conserved SAM binding domain with architecture compatible with classic alternating β-stranded and α-helical regions. KerV does not show any other conserved motif that could indicate its methylation substrate. Heterologous expression in E. coli showed that KerV is partially soluble only when co-expressed with GroeL/GroES chaperones at low temperatures or when KerV is in fusion with MBP or GST tag. During the purification process KerV was copurified with GroEL chaperone suggesting that this association may be required for the correct folding of KerV. Methyltransferase activity and SAM binding assays were done with purified MBPKerV and the results were not conclusive since the proper conformation of MBP-KerV cannot be verified. Yeast two-hybrid assays indicated that RNaseH and DnaQ are not interaction partners of KerV, suggesting that their functions are not directly related. The mutation frequency of D12 strain increased only about four times in relation to PA14, suggesting that KerV is not directly involved with DNA mismatch repair. The assays to detect methylation in DNA, RNAs and proteins do not show that KerV is involved with methylation of these substrates. The transcription start sites of kerV, rnhA and dnaQ genes were mapped through 5\'-RACE- and primer extension experiments. The kerV deletion causes a polar effect on the transcription of rnhA gene, which is not reflected on RNaseH protein levels. The kerV deletion also affects dnaQ expression, suggesting that KerV is important for its regulation.The virulence complementation assays in flies and lung epithelial cells showed that the fully rescue of the wild type phenotype was achieved only when the entire locus is present. KerV was essential to inhibit the NF-kB nucleus translocation, demonstrating that KerV is relevant to PA14 virulence, contributing for the silencing of host immune system. Altogether, these data showed a complex inter-relation among kerV, rnhA and dnaQ genes and its role in P. aeruginosa biology
|
647 |
Efeito dos reguladores de resposta PvrR e RcsB na motilidade, formação de biofilme e sua relação com a fímbria CupD de Pseudomonas aeruginosa PA14 / Effect of PvrR and RcsB response regulators in motility, biofilm formation and their connection with Pseudomonas aeruginosa PA14 CupD fimbriaGianlucca Gonçalves Nicastro 09 December 2008 (has links)
Pseudomonas aeruginosa é uma proteobactéria do grupo gama, que pode se comportar como um patógeno oportunista. A linhagem PA14 apresenta duas ilhas de patogenicidade. A maior delas, PAPI-1, contém dois grupos de genes envolvidos com virulência, transcritos de maneira oposta e que estão entre duas seqüências repetidas diretas. O primeiro grupo compreende quatro genes dispostos em dois operons, que codificam para proteínas de sistemas de dois componentes (PvrS, PvrR, RcsC e RcsB). PvrS e RcsC são proteínas sensoras híbridas, que apresentam domínios de histidina-quinase e de reguladores de resposta. PvrR é um regulador de resposta com um domínio EAL com atividade de fosfodiesterase de diGMP cíclico e RcsB apresenta um domínio de ligação a DNA, além de um domínio fosfoaceptor. O outro grupo é composto de cinco genes, cupD1 a cupD5, que codificam para uma fímbria do tipo chaperone-usher e que apresenta alta similaridade com cupA, envolvido na formação de biofilme em outras linhagens de P. aeruginosa. Trabalhos anteriores mostraram que pvrS, pvrR, rcsC, rcsB e cupD2 estão relacionados com a virulência de PA14. Como estes grupos de genes parecem ter sido inseridos na ilha em um único evento de recombinação, este trabalho investigou se os sistemas de dois componentes estão relacionados com a regulação da expressão de cupD. Foi observado que a expressão de cupD é maior a 28ºC do que que a 37ºC e é influenciada positivamente pelo regulador global de expressão, MvaT, uma proteína tipo H-NS. Ensaios de β-galactosidase a partir de uma fusão de transcrição mostraram que a atividade promotora de cupD é cerca de 50% menor numa linhagem com deleção em rcsB em relação à linhagem selvagem. Nenhuma diferença consistente foi observada entre as linhagens com deleções em pvrS, pvrR, rcsC e rcsB e PA14 em relação a motilidade dos tipos swarming, swimming ou twitching ou à formação de biofilme. A linhagem de P. aeruginosa PA14 superexpressando RcsB mostrou níveis exacerbados de mRNA de cupD1, sendo a atuação de RcsB específica em cupD, já que os outros grupos de genes cup presentes em PA14 não mostraram a mesma variação na expressão, conforme analisado por RT-PCR quantitativo. Essa linhagem mostrou também um aumento na formação de biofilme, sem que a motilidade fosse alterada. Ainda visando elucidar os mecanismos de regulação de cupD, linhagens que superexpressam pvrR também foram analisadas quanto a estes fenótipos. Nesse caso, a superexpressão de pvrR diminuiu a formação de biofilme, conforme esperado, aumentou a motilidade do tipo swarming, porém não alterou a expressão de cupD. Os dados do presente trabalho demonstraram que a cupD é regulado pelos genes do sistemas de dois componentes adjacentes a ele e que o ativador de transcrição RcsB está relacionado com a formação de biofilme em tubos de vidro, provavelmente via a fímbria CupD. / Pseudomonas aeruginosa is a γ-proteobacteria that can behave as an opportunistic pathogen. The strain PA14 carries two pathogenicity islands, the largest of them, PAPI-1, contains two gene clusters between two direct repeat sequences that are transcribed in opposite directions and are involved in virulence. The first group consists of four genes arranged in two operons encoding two-component system proteins (PvrS, PvrR, RcsC and RcsB). PvrS and RcsC are hybrid sensor proteins, which contain domains of histidine kinase and response regulator domains. PvrR is a response regulator with a phosphodiesterase EAL domain and RcsB presents a C- terminal HTH DNA biding domain, in addition to a phosphoaceptor domain. The other group is composed of five genes, cupD1-5, that encodes components and assembly factors of a putative fimbrial CupD, which has high similarity with CupA, involved in the biofilm formation in other P. aeruginosa strains. Earlier work showed that pvrS, pvrR, rcsC, rcsB and cupD2 are related to the virulence of PA14. As these groups of genes appear to have been inserted on the island in a single event of recombination, this study investigated whether the two-component systems are related to the regulation of cupD expression. It was observed that cupD promoter activity is higher at 28oC than at 37oC and it is positively influenced by the global regulator, MvaT, a H-NS like protein. A lacZ transcriptional fusion showed about 50% less promoter activity of cupD from a strain with deletion in rcsB as compared to PA14. No consistent differences were found among the strains with deletions in pvrS, pvrR, rcsC and rcsB and PA14 on swarming, swimming and twitching motilities or biofilmsformation. A strain overexpressing overexpression showed heigher levels of cupD1mRNA of, and the role of RcsB as an activator is specific to cupD, as the other groups of cup genes present in PA14 did not show the same variation in the expression, as analyzed by quantitative RT-PCR. This strain also showed an increase in biofilm formation. In further assays aiming to elucidate the mechanisms of regulation of cupD, a strains overexpressing pvrR was also analyzed. Overexpression of pvrR decreased the formation of biofilm, as expected, and increased swarming motility, but did not alter the expression of cupD. The data from this study demonstrated that cupD is regulated by RcsB, and that this transcriptional activator is involved in the formation of biofilm in glass tubes, probably via CupD fimbriae.
|
648 |
Étude du rôle de CHAC1 dans la modulation de la réponse des cellules épithéliales bronchiques infectées par Pseudomonas aeruginosa dans le contexte de la mucoviscidose / Study of the role of CHAC1 in the modulation of the response of bronchial epithelial cells infected with Pseudomonas aeruginosa in the context of cystic fibrosisPerra, Léa 27 September 2018 (has links)
Dans la mucoviscidose (CF), Pseudomonas aeruginosa colonise les voies respiratoires, conduisant à une inflammation chronique de l’épithélium bronchique. Une analyse transcriptomique antérieure nous a permis d’identifier CHAC1 comme un gène différentiellement exprimé entre les cellules épithéliales bronchiques primaires de patients CF et non-CF, au niveau basal et au cours de l’infection à P. aeruginosa. CHAC1 est une protéine dégradant le glutathion et associée au stress du réticulum endoplasmique et à l’apoptose. L’objectif principal de ce travail était de comprendre la contribution de CHAC1, en particulier dans la réponse inflammatoire et l’apoptose des cellules épithéliales pulmonaires. Nous avons donc, dans un premier temps, confirmé que CHAC1 est surexprimé au niveau ARNm dans les cellules épithéliales bronchiques primaires non-CF par rapport aux cellules CF. Nous avons observé que P. aeruginosa et deux de ses facteurs de virulence, le LPS et la flagelline, induisent l’expression de CHAC1 dans les cellules non-CF. L’expression de CHAC1 induite par le LPS est indépendante de PERK mais implique ATF4. De plus, nous avons observé qu’une réduction de l’expression de CHAC1 est associée, après stimulation par du LPS et de la flagelline, à une modulation des marqueurs inflammatoires notamment l’IL-8, l’IL-6, CCL2 et PGE2. Enfin, nous avons montré que P. aeruginosa n’est pas capable d’induire de l’apoptose dans la lignée de cellules épithéliales bronchiques NCI-H292. Ces résultats suggèrent que la régulation de l’expression de CHAC1 dans les cellules CF pourrait contribuer à la réponse inflammatoire excessive et chronique observée chez les patients atteints de mucoviscidose. / In cystic fibrosis (CF), Pseudomonas aeruginosa colonizes the airways, leading to chronic inflammation of the bronchial epithelium. A previous transcriptomic analysis allowed us to identify CHAC1 as a gene differentially expressed between primary bronchial epithelial cells of CF and non-CF patients at the basal level and during P. aeruginosa infection. CHAC1 is a glutathione-degrading protein associated with endoplasmic reticulum stress and apoptosis. The main objective of this work was to understand the contribution of CHAC1, particularly in the inflammatory response and apoptosis of pulmonary epithelial cells. We therefore first confirmed that CHAC1 is overexpressed at the mRNA level in non-CF primary bronchial epithelial cells relative to CF cells. We observed that P. aeruginosa and two of its virulence factors, LPS and flagellin, induce CHAC1 expression in non-CF cells. The expression of CHAC1 induced by LPS is independent of PERK but involves ATF4. Moreover, we have observed that a reduction in the expression of CHAC1 is associated, after stimulation by LPS and flagellin, with a modulation of the inflammatory markers, in particular IL-8, IL-6, CCL2 and PGE2. Finally, we have shown that P. aeruginosa is not capable of inducing apoptosis in the NCI-H292 bronchial epithelial cell line. These results suggest that CHAC1 is involved in the regulation of bronchial cell inflammation during P. aeruginosa infection and the regulation of CHAC1 expression in CF cells may contribute to the observed excessive and chronic inflammatory response in patients with cystic fibrosis.
|
649 |
Approche métabolomique pour l'étude de l'évolution adaptative de Pseudomonas aeruginosa au cours des infections pulmonaires chroniques dans la mucoviscidose / A metabolomics approach to study within-host adaptation of Pseudomonas aeruginosa during cystic fibrosis chronic lung infectionsMoyne, Oriane 29 March 2019 (has links)
L’infection pulmonaire chronique à Pseudomonas aeruginosa (P. a.) est considérée comme la principalecause de morbidité et de mortalité liée à la mucoviscidose. Au cours de cette infection persistante, labactérie s'adapte à l’environnement pulmonaire caractéristique de ces patients et évolue avec son hôtependant des décennies. Cette évolution adaptative est portée par les phénotypes, avec notamment unediminution de la virulence et une augmentation de la résistance aux antibiotiques au cours du temps. Bienque plusieurs études aient tenté d’évaluer les mécanismes génétiques de cette évolution, il demeureaujourd’hui difficile d’expliquer les relations entre les mutations accumulées dans le génome bactérien etl’expression de phénotypes cliniquement pertinents, ou encore de corréler ces mutations avec l’état desanté du patient.Nous proposons dans ce travail d’étudier les mécanismes sous-tendant cette évolution adaptative à unniveau d’observation post-génomique : la métabolomique. Dernière-née des disciplines –omiques, lamétabolomique permet la prise de vue instantanée du métabolisme, et offre une vision au plus proche duphénotype. Pour cela, nous avons constitué une banque de lignées clonales évolutives de P. a. prélevéesau cours de l’infection pulmonaire chronique chez des patients atteints de mucoviscidose. Cette banque aensuite été caractérisée aux plans clinique, phénotypique et métabolomique. L’intégration de ces différentsniveaux d’information par des méthodes statistiques multi-tableaux nous a permis de mettre en évidencedes voies métaboliques impliquées dans la patho-adaptation de P. a. à son hôte.Nos résultats permettent de faire émerger de nouvelles hypothèses pour le développement d’outilsthérapeutiques et diagnostiques visant à améliorer la prise en charge de ces infections particulièrementrésistantes aux antibiotiques. De plus, nos travaux démontrent l’intérêt de la métabolomique pour l’étudede l’évolution adaptative bactérienne en conditions naturelles. / Chronic lung infection with Pseudomonas aeruginosa (P. a.) is considered as the leading cause of cysticfibrosis (CF) morbidity and mortality. During this persistent infection, the bacterium adapts to the typical lungenvironment of these patients and evolves within its host for decades. This adaptive evolution is driven byphenotypes, including a decrease in virulence and an increase in antibiotic resistance over time. Althoughseveral studies have attempted to elucidate the genetic mechanisms of this evolution, it remains difficulttoday to explain the relationships between the accumulated genomic mutations and the expression ofclinically relevant phenotypes, or to correlate these mutations with the patient’s health status.In this work, we propose to study the mechanisms underlying this adaptive evolution at a post-genomicobservation level: metabolomics. Metabolomics, the newest of the -omics disciplines, provides an instantview of the metabolic activities, and furnishes a vision as close as possible to the phenotype. To this end,we constructed a bank of evolutive clonal P. a. lineages sampled during chronic lung infection in patientswith CF. This bank was then clinically, phenotypically and metabolomically characterized. Integration ofthese different levels of information by multi-block statistical methods has allowed us to highlight metabolicpathways involved in within-host patho-adaptation of P. a. .Our results rise new hypotheses for the development of therapeutic and diagnostic tools with the aim ofimproving the management of these infections particularly resistant to antibiotics. In addition, our workdemonstrates the interest of metabolomics to study bacterial adaptive evolution under natural conditions.
|
650 |
Contribution à l'étude du système BAC "Biofilm Associated Cluster" chez Pseudomanas aeruginosa. / Contribution to the study of BAC "Biofilm Associated Cluster" in Pseudomonas AeruginosaSaffiedine, Brahim 03 July 2019 (has links)
Pseudomonas aeruginosa (PA) est une bactérie Gram négatif, pathogène opportuniste, impliquée dans un grand nombre d’infections nosocomiales. Cette bactérie est aussi le principal micro-organisme responsable des surinfections broncho-pulmonaires chez les patients atteints de mucoviscidose. Cette prééminence est due en partie à la capacité de PA à former des biofilms, ce qui lui confèrent une résistance exceptionnelle aux antimicrobiens. Au sein de notre laboratoire, une analyse protéomique différentielle a permis de démontrer, en 2004, l’existence d’un protéome spécifique lorsque la bactérie se développe en mode biofilm. Parmi les protéines spécifiquement exprimées en mode biofilm, la protéine hypothétique PA3731 a été plus particulièrement étudiée. Cette protéine est impliquée dans la formation de biofilm, la production de rhamnolipides, la résistance à la tobramycine et la mobilité de type « swarming ». Des recherches bioinformatiques ont montré que le gène pA3731 appartient à un cluster de 4 gènes allant de pA3729 à pA3732 (système BAC), qui pourraient être impliqués dans l’élaboration et/ou la régulation d’un même système protéique. Cette hypothèse a constitué le point de départ de ce travail de thèse. La présente étude a permis de confirmer l’implication du système BAC dans la formation du biofilm, la résistance aux antibiotiques et la production de rhamnolipides chez PA. Les études protéomiques ont mis en évidence l’implication de ce système dans l’expression de la pompe MexEF-OprN, de la porine OprD, et dans la régulation du Quorum Sensing. Des études intéractomiques, menées en parallèle, ont montré une forte interaction entre la protéine PA3731 et PA3732. Ces études ont également permis de valider une forte interaction entre ces protéines et les rhamnolipides. L’ensemble de ces résultats nous permettent d’avancer une hypothèse quant à l’implication du système BAC dans le transport des rhamnolipides vers le milieu extracellulaire. / Pseudomonas aeruginosa (PA) is a Gram-negative bacterium, opportunistic pathogen, involved in a large number of nosocomial infections. This microorganism is also the main infectious agent involved in bronchopulmonary infections in cystic fibrosis patients. This pre-eminence is partly due to the ability of PA to form biofilms, which confers to the bacterial cells an increased resistance to antibiotics. In our laboratory, a differential proteomic analysis allowed to demonstrate in 2004, the existence of a specific proteome when the bacterium grows in the biofilm mode. This study allowed identifying about 40 proteins, specifically accumulated when bacteria adhere to a surface. Among these proteins, the hypothetical protein PA3731 has been particularly investigated. This protein is involved in the biofilm formation, the rhamnolipids production, the resistance to tobramycin and the swarming mobility. Bioinformatic research showed that the pA3731 gene belongs to a cluster of 4 genes ranging from pA3729 to pA3732 (BAC system), which could be involved in the development and / or regulation of the same protein system. This hypothesis was the starting point of this thesis work. The present study confirmed the involvement of the BAC system in the biofilm formation, the antibiotic resistance and the rhamnolipid production in PA. Proteomic studies highlighted the implication of this system in the expression of the MexEF-OprN pump and that of the OprD porin, and in the regulation of Quorum Sensing. Interactomic investigations, conducted in parallel, showed a strong interaction between PA3731 and PA3732 proteins. These studies have also pointed out a strong interaction between these proteins and rhamnolipids. All these results suggest that the BAC system could play a major role in the transfer of rhamnolipids to the extracellular environment.
|
Page generated in 0.7372 seconds